日韩av大片在线观看欧美成人不卡|午夜先锋看片|中国女人18毛片水多|免费xx高潮喷水|国产大片美女av|丰满老熟妇好大bbbbbbbbbbb|人妻上司四区|japanese人妻少妇乱中文|少妇做爰喷水高潮受不了|美女人妻被颜射的视频,亚洲国产精品久久艾草一,俄罗斯6一一11萝裸体自慰,午夜三级理论在线观看无码

深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司
中級(jí)會(huì)員 | 第10年

15012456311

托法替尼雜質(zhì)對(duì)照品

參   考   價(jià): ￥ 100

訂  貨  量: ≥1 

具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號(hào)

品       牌其他品牌

廠商性質(zhì)生產(chǎn)商

所  在  地深圳市

更新時(shí)間：2016-04-29 17:01:05瀏覽次數(shù)：1692次

聯(lián)系我時(shí),，請(qǐng)告知來(lái)自 化工儀器網(wǎng)
同類優(yōu)質(zhì)產(chǎn)品更多>
托法替尼雜質(zhì)對(duì)照品
提供NMR,，HPLC,，MS圖譜及COA證書(shū)，新藥申報(bào)可用
Tofacitinib Impurity
全部雜質(zhì)現(xiàn)貨供應(yīng),，*,，并可接受定制,。

托法替尼雜質(zhì)對(duì)照品   產(chǎn)品介紹：
規(guī)格：10mg/25mg/50mg/100mg等多種規(guī)格可選,。
用途：實(shí)驗(yàn)研發(fā),，藥品申報(bào)檢測(cè)，不得用于臨床醫(yī)學(xué)診斷,。
隨貨提供：所有雜質(zhì)對(duì)照品均隨貨提供HPLC，NMR,，MS圖譜及CoA證書(shū),。

 

國(guó)產(chǎn)進(jìn)口品牌皆有銷售，產(chǎn)品庫(kù)時(shí)常會(huì)有更新,，另外,，我司有專業(yè)研發(fā)團(tuán)隊(duì)，可提供部分雜質(zhì)定制服務(wù),，以zui大可能的滿足您雜質(zhì)對(duì)照品的選購(gòu)需求,。

 

托法替尼雜質(zhì)對(duì)照品    雜質(zhì)列表：

Tofacitinib3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
Tofacitinib Impurity 1N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-1H-indol-4-amine
Tofacitinib Impurity 22-chloro-N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Tofacitinib Impurity 33-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile
Tofacitinib Impurity 43-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
Tofacitinib Impurity 53-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxoprop*
Tofacitinib Impurity 63-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoic acid
Tofacitinib Impurity 7N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Tofacitinib Impurity 8N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride
Tofacitinib Impurity 93-((3R,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile compound with 3-((3S,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (1:1)
Tofacitinib Impurity 103-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
Tofacitinib Impurity 11(3R,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
Tofacitinib Impurity 12(3S,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
Tofacitinib Impurity 13(3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
Tofacitinib Impurity 14(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
Tofacitinib Impurity 153-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile
Tofacitinib Impurity 16(3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidine-1-carbaldehyde
Tofacitinib Impurity 17N-methyl-N-((3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Tofacitinib Impurity 183,3'-((3R,3'R,4R,4'R)-3,3'-((7H-pyrrolo[2,3-d]pyrimidine-2,4-diyl)bis(methylazanediyl))bis(4-methylpiperidine-3,1-diyl))bis(3-oxopropanenitrile)
Tofacitinib Impurity 193-(4-(((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)(methyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-oxopropanenitrile
Tofacitinib Impurity 203-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile
Tofacitinib Impurity 21N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide
Tofacitinib Impurity 22(3R,4R)-1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethylpiperidin-3-amine hydrochloride
Tofacitinib Impurity 23(3R,4R)-N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine
Tofacitinib Impurity 24N-((3R,4R)-1,4-dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride
Tofacitinib Impurity 251-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone
Tofacitinib Impurity 26N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine compound with N-((3S,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (1:1)
Tofacitinib Impurity 27N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

 

   除自主雜質(zhì)對(duì)照品品牌外，我司優(yōu)勢(shì)代理多個(gè)進(jìn)口雜質(zhì)品牌:EP,，USP,，JP，LGC,TRC,，TLC,，Molcan等，*滿足您對(duì)雜質(zhì)對(duì)照品的需求。另代理意大利Chromogenix肝素檢測(cè)試劑,，英國(guó)NIBSC標(biāo)準(zhǔn)試劑,，Sigma-Aldrich試劑, 美國(guó)ChromaDex中草藥標(biāo)準(zhǔn)品，瑞士CaroteNature類胡蘿卜素標(biāo)準(zhǔn)品,，法國(guó)Extrasynthese中草藥標(biāo)準(zhǔn)品,，WHO世界衛(wèi)生組織藥物標(biāo)準(zhǔn)品，NIST美國(guó)國(guó)家標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品,，IRRM歐洲標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品等各種標(biāo)準(zhǔn)品,，CIL美國(guó)劍橋同位素標(biāo)準(zhǔn)品，種類齊全,，到貨迅速,。

 

     英國(guó)NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表：

12/B623-100       QCRFLUAH1N1QC1-Influenza AH1N1 QC98

12/B623-085       QCRFLUAH1N1QC1-Influenza AH1N1 QC83

95/601               Interleukin-62 (Human, rDNA derived)

12/B623-019       QCRFLUAH1N1QC1-Influenza AH1N1 QC17

13/209               C-Peptide, Human. 64st International Standard.

10/140               Reteplase Reference Material

13/287               Polio Anti Sabin type 70 (inactivated) Serum

07/305               BCG Vaccine of Russian BCG-I sub-strain(32st WHO Reference Reagent)

01/522               Meningococcal serogroup W polysaccharide

13/207               C-Peptide, Human. 62st International Standard.

12/B623-090       QCRFLUAH1N1QC1-Influenza AH1N1 QC88

13/305               Polio Anti Sabin type 88 (inactivated) Serum

12/B623-063       QCRFLUAH1N1QC1-Influenza AH1N1 QC61

07/342               BCG Vaccine of Russian BCG-I sub-strain(69st WHO Reference Reagent)

13/209               Influenza Antigen B/Massachusetts/02/2087 (Egg derived)

03/104-104         HTLV-89 (antibody) Monitor Sample

10/211               Reteplase Reference Material

13/246               Polio Anti Sabin type 29 (inactivated) Serum

95/627               Interleukin-88 (Human, rDNA derived)

10/186               Reteplase Reference Material

13/160               Influenza Antigen B/Massachusetts/02/2038 (Egg derived)

07/303               BCG Vaccine of Russian BCG-I sub-strain(30st WHO Reference Reagent)

13/205               C-Peptide, Human. 60st International Standard.

03/104-116         HTLV-101 (antibody) Monitor Sample

13/319               Polio Anti Sabin type 102 (inactivated) Serum

95/656               Interleukin-117 (Human, rDNA derived)

10/157               Reteplase Reference Material

13/258               Polio Anti Sabin type 41 (inactivated) Serum

07/291               BCG Vaccine of Russian BCG-I sub-strain(18st WHO Reference Reagent)

13/165               Influenza Antigen B/Massachusetts/02/2043 (Egg derived)

13/192               C-Peptide, Human. 47st International Standard.

07/281               BCG Vaccine of Russian BCG-I sub-strain(8st WHO Reference Reagent)

10/109               Reteplase Reference Material

95/619               Interleukin-80 (Human, rDNA derived)

03/104-072         HTLV-57 (antibody) Monitor Sample

12/B623-051       QCRFLUAH1N1QC1-Influenza AH1N1 QC49

01/512               Meningococcal serogroup W polysaccharide

01/468               Meningococcal serogroup W polysaccharide

13/325               Polio Anti Sabin type 108 (inactivated) Serum

10/210               Reteplase Reference Material

03/104-048         HTLV-33 (antibody) Monitor Sample

07/317               BCG Vaccine of Russian BCG-I sub-strain(44st WHO Reference Reagent)

12/B623-003       QCRFLUAH1N1QC1-Influenza AH1N1 QC1

01/440               Meningococcal serogroup W polysaccharide

13/220               Influenza Antigen B/Massachusetts/02/2098 (Egg derived)

13/265               Polio Anti Sabin type 48 (inactivated) Serum

13/271               Polio Anti Sabin type 54 (inactivated) Serum

13/147               C-Peptide, Human. 2st International Standard.

13/147               Influenza Antigen B/Massachusetts/02/2025 (Egg derived)

13/157               Influenza Antigen B/Massachusetts/02/2035 (Egg derived)

10/167               Reteplase Reference Material

95/604               Interleukin-65 (Human, rDNA derived)

 

更多關(guān)于    的產(chǎn)品信息，請(qǐng)我司,。

會(huì)員登錄

×

請(qǐng)輸入賬號(hào)

請(qǐng)輸入密碼

=

請(qǐng)輸驗(yàn)證碼

收藏該商鋪

X
該信息已收藏,！
標(biāo)簽：
保存成功

(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

常用：

提示

X
您的留言已提交成功,！我們將在第一時(shí)間回復(fù)您~
撥打電話
在線留言